Hyun Jung Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hyun Jung Park has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jong Kyun Lee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication - Joo Kyung Park
Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea
1 shared publication - Kwang Hyuck Lee
Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea
1 shared publication - Kyu Taek Lee
Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea
1 shared publication - Young Hoon Choi
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 31 July 2024
- Published by Korean Pancreatobiliary Association in The Korean Journal of Pancreas and Biliary Tract
- Vol. 29 (3) , 110-114
A Case of Five-Year Survival in Metastatic Pancreatic Cancer
Pancreatic cancer is often diagnosed at advanced stage, where chemotherapy is the mainstay of treatment. Despite new chemotherapy regimens improving overall survival over the past decade, the median survival for advanced pancreatic cancer remains around one year. However, we occasionally encounter long-term survivors among patients with advanced pancreatic cancer. Analyzing these cases may provide valuable insights for understanding pancreatic cancer and improving treatment strategies. We report a case of 61-year-old patient with metastatic pancreatic cancer who survived for approximately five years. Single-cell transcriptome analysis of tissues obtained at the time of pancreatic cancer diagnosis and at 57 months post-diagnosis revealed changes in the tumor immune microenvironment.
- 31 July 2024
- Published by Korean Pancreatobiliary Association in The Korean Journal of Pancreas and Biliary Tract
- Vol. 29 (3) , 110-114
Open AccessA Case of Five-Year Survival in Metastatic Pancreatic Cancer
Pancreatic cancer is often diagnosed at advanced stage, where chemotherapy is the mainstay of treatment. Despite new chemotherapy regimens improving overall survival over the past decade, the median survival for advanced pancreatic cancer remains around one year. However, we occasionally encounter long-term survivors among patients with advanced pancreatic cancer. Analyzing these cases may provide valuable insights for understanding pancreatic cancer and improving treatment strategies. We report a case of 61-year-old patient with metastatic pancreatic cancer who survived for approximately five years. Single-cell transcriptome analysis of tissues obtained at the time of pancreatic cancer diagnosis and at 57 months post-diagnosis revealed changes in the tumor immune microenvironment.